Primary mediastinal large B-cell lymphoma

Revision as of 15:05, 7 March 2016 by Sowminya Arikapudi (talk | contribs) (Created page with "__NOTOC__ {{SI}} '''For patient information, click Insert page name here''' {{CMG}}; {{AE}} {{AS}} {{SK}}: == Overview ==...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Primary mediastinal large B-cell lymphoma

Articles

Most recent articles on Primary mediastinal large B-cell lymphoma

Most cited articles on Primary mediastinal large B-cell lymphoma

Review articles on Primary mediastinal large B-cell lymphoma

Articles on Primary mediastinal large B-cell lymphoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Primary mediastinal large B-cell lymphoma

Images of Primary mediastinal large B-cell lymphoma

Photos of Primary mediastinal large B-cell lymphoma

Podcasts & MP3s on Primary mediastinal large B-cell lymphoma

Videos on Primary mediastinal large B-cell lymphoma

Evidence Based Medicine

Cochrane Collaboration on Primary mediastinal large B-cell lymphoma

Bandolier on Primary mediastinal large B-cell lymphoma

TRIP on Primary mediastinal large B-cell lymphoma

Clinical Trials

Ongoing Trials on Primary mediastinal large B-cell lymphoma at Clinical Trials.gov

Trial results on Primary mediastinal large B-cell lymphoma

Clinical Trials on Primary mediastinal large B-cell lymphoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Primary mediastinal large B-cell lymphoma

NICE Guidance on Primary mediastinal large B-cell lymphoma

NHS PRODIGY Guidance

FDA on Primary mediastinal large B-cell lymphoma

CDC on Primary mediastinal large B-cell lymphoma

Books

Books on Primary mediastinal large B-cell lymphoma

News

Primary mediastinal large B-cell lymphoma in the news

Be alerted to news on Primary mediastinal large B-cell lymphoma

News trends on Primary mediastinal large B-cell lymphoma

Commentary

Blogs on Primary mediastinal large B-cell lymphoma

Definitions

Definitions of Primary mediastinal large B-cell lymphoma

Patient Resources / Community

Patient resources on Primary mediastinal large B-cell lymphoma

Discussion groups on Primary mediastinal large B-cell lymphoma

Patient Handouts on Primary mediastinal large B-cell lymphoma

Directions to Hospitals Treating Primary mediastinal large B-cell lymphoma

Risk calculators and risk factors for Primary mediastinal large B-cell lymphoma

Healthcare Provider Resources

Symptoms of Primary mediastinal large B-cell lymphoma

Causes & Risk Factors for Primary mediastinal large B-cell lymphoma

Diagnostic studies for Primary mediastinal large B-cell lymphoma

Treatment of Primary mediastinal large B-cell lymphoma

Continuing Medical Education (CME)

CME Programs on Primary mediastinal large B-cell lymphoma

International

Primary mediastinal large B-cell lymphoma en Espanol

Primary mediastinal large B-cell lymphoma en Francais

Business

Primary mediastinal large B-cell lymphoma in the Marketplace

Patents on Primary mediastinal large B-cell lymphoma

Experimental / Informatics

List of terms related to Primary mediastinal large B-cell lymphoma

For patient information, click Insert page name here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Synonyms and keywords::

Overview

Pathophysiology

Associated Conditions

Microscopic Pathology

On microscopic histopathological analysis, centrocytes, centroblasts, plasma cells, and immunoblasts are characteristic findings of nodal marginal zone lymphoma.

Causes

There are no established causes for primary mediastinal large B-cell lymphoma.

Differentiating type page name here from other Diseases

Primary mediastinal large B-cell lymphoma must be differentiated from other diseases such as:

Epidemiology and Demographics

Age

The incidence of primary mediastinal large B-cell lymphoma increases with age; the median age at diagnosis is 35 years.

Gender

Females are more commonly affected with primary mediastinal large B-cell lymphoma than males.

Risk Factors

There are no established risk factors for primary mediastinal large B-cell lymphoma.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for primary mediastinal large B-cell lymphoma.

Natural History, Complications and Prognosis

Diagnosis

Staging

Staging for primary mediastinal large B-cell lymphoma is provided in the following table:[1]

Revised staging system for primary nodal lymphomas (Lugano classification)
Stage Involvement Extranodal (E) status
Limited
Stage I One node or a group of adjacent nodes Single extranodal lesions without nodal involvement
Stage II Two or more nodal groups on the same side of the diaphragm Stage I or II by nodal extent with limited contiguous extranodal involvement
Stage II bulky II as above with "bulky" disease Not applicable
Advanced
Stage III Nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement Not applicable
Stage IV Additional noncontiguous extralymphatic involvement Not applicable

Symptoms

Symptoms of the primary mediastinal large B-cell lymphoma include:

Physical Examination

Vitals

HEENT

Thorax

Abdomen

Extremities

Laboratory Findings

Laboratory tests for primary mediastinal large B-cell lymphoma include:

Biopsy

Lymph node or bone marrow biopsy is diagnostic of .

CT

CT scan may be helpful in the diagnosis of primary mediastinal large B-cell lymphoma.

MRI

MRI scan may be helpful in the diagnosis of primary mediastinal large B-cell lymphoma.

Other Imaging Findings

PET scan may be helpful in the diagnosis of primary mediastinal large B-cell lymphoma.

Treatment

Medical Therapy

Treatment of primary mediastinal large B-cell lymphoma[2]
Therapy Description
Chemotherapy
Biological therapy
Radiation therapy
Stem cell transplant

References

  1. Cheson, Bruce D.; Fisher, Richard I.; Barrington, Sally F.; Cavalli, Franco; Schwartz, Lawrence H.; Zucca, Emanuele; Lister, T. Andrew; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer/Dutch Hemato-Oncology Group; Grupo Español de Médula Ósea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group; United Kingdom National Cancer Research Institute (2014-09-20). "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification". Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 32 (27): 3059–3068. doi:10.1200/JCO.2013.54.8800. ISSN 1527-7755. PMID 25113753.
  2. Nodal marginal zone lymphoma . Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/nodal-marginal-zone-lymphoma/?region=nb Accessed on March 4, 2016